Board of Directors 2023-2024
President (2023-2024)
Brian O'Rourke, PharmD, CD, OMM
President, Brian O'Rourke Health Care Consulting, Inc
Ottawa, Canada
Past President (2023-2024)
Jan Elias Hansen, PhD
Vice President, Evidence for Access Unit - Genentech’s US Medical Affairs
South San Francisco, California, USA
President-Elect (2023-2024)
Eberechukwu Onukwugha, PhD
Professor, University of Maryland.
Baltimore, Maryland, USA
Director (2023 – 2026)
Dalia Dawoud, PhD
Associate Director (Research), The National Institute for Health and Care Excellence (NICE),
London, England, UK
Biography and Vision Statement
Director (2021-2024)
Beth Devine, PhD
Professor, Graduate Program Director, The Comparative Heath Outcomes, Policy and Economics (CHOICE) Institute, School of Pharmacy, University of Washington
Seattle, Washington, USA
Director (2021-2024)
Marlene Gyldmark, MPhil
Global Head HEOR and Epidemiology, Idorsia Pharmaceuticals, Ltd
Basel, Switzerland
Director (2021-2024)
Andrea Manca, MSc PhD
Professor, Centre for Health Economics at the University of York
York, England, UK
Biography and Vision Statement
Director (2023 – 2026)
Lucinda Orsini, DPM, MPH
Vice President for Value and Outcomes Research, COMPASS Pathways
Skillman, New Jersey, USA
Biography and Vision Statement
Director (2023-2026)
Amy O’Sullivan, PhD
Senior Vice President and Chief Scientific Officer, Ontada
Boston, Massachusetts, USA
Biography and Vision Statement
Director (2021-2024)
Dong-Churl Suh, PhD
Professor and Director of the Graduate Program at the Chung-Ang University College of Pharmacy
Seoul, South Korea
Treasurer (2020-2026)
Sean D. Sullivan, BScPharm, MSc, PhD,
Professor and Dean, University of Washington, School of Pharmacy
Seattle, Washington, USA
CEO & Executive Director
Rob Abbott
CEO & Executive Director
ISPOR-The Professional Society for Health Economics and Outcomes Research
Lawrenceville, New Jersey, USA